Good Clinical Practice and protocol procedure compliance

The manuals converge on the expectation that trial staff work within Good Clinical Practice, approved protocol procedures, and the relevant ethics and regulatory framework. Across the extracts, this includes using only approved study documents, following delegated responsibilities, keeping source data and case report forms accurate and timely, and supporting participant safety, confidentiality, and data integrity. They also converge on the need to recognise and report protocol deviations, with several manuals noting that deviations, major concerns, safety issues, or blind breaks require escalation through the required channels. Monitoring, auditing, inspection readiness, and source-data verification are also recurring themes, showing a shared emphasis on verifiable trial conduct. The manuals differ in the regulatory details they name. Some refer to ICH GCP, Helsinki principles, and local ethics committee approval, while others add TCPS 2, PHIPA, FDA or Food and Drug Regulations, DEA Schedule I licensing, sponsor instructions, or specific IRB or REB processes. A few extracts place extra emphasis on role boundaries and supervision, such as working only within delegated responsibilities or ensuring supervised staff are fully informed, while others highlight conflict of interest transparency or controlled-substance handling.